Anti-Human ITGB2 Therapeutic Antibody (Rovelizumab)
Recombinant monoclonal antibody to CD18. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock.
Supplier | Creative Biolabs |
---|---|
Product # | TAB-044 |
Pricing | Inquiry |
Host | Mouse |
Target | ITGB2 |
Species Reactivity | Human |
Type | IgG4 |
Applications | Suitable for use in Neut, ELISA, IF, IP, FuncS, FC, IHC and most other immunological methods. |
Storage | 4°C. For long term storage, aliquot and store at -20°C. Repeated thawing and freezing must be avoided. |